Research Scientist
CureVac SE
Tübingen, Germany
Paula Muresan obtained a PhD from the University of Nottingham, CDT Advanced Therapeutics and Nanomedicines in 2021. She started working as a Research Scientist at CureVac SE (Germany) in 2022, focusing on the design and development of lipid nanoparticles (LNPs) for the delivery of mRNA therapeutics, structural characterization, and process optimization.
Disclosure information not submitted.
Nanomedicine and Nanoscale Delivery IV
Wednesday, July 10, 2024
2:30 PM – 4:30 PM CET
